Statistical Considerations for Planning Clinical Trials with Quantitative Imaging Biomarkers
Abstract As imaging technologies and treatment options continue to advance, imaging outcome measures are becoming increasingly utilized as the basis of making major decisions in new drug development and clinical practice. Quantitative imaging biomarkers (QIBs) are now commonly used for subject selec...
Gespeichert in:
Veröffentlicht in: | JNCI : Journal of the National Cancer Institute 2019-01, Vol.111 (1), p.19-26 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!